Riskpilot← Back to searchSign inGet full accessGalenica Derma AB
ABActiveOrg 5593966996MalmöWholesale of pharmaceutical and medical goods · NACE 4646Est. 20226 employees
Revenue 2025
SEK 17,6M
-3% vs 2024
EBITDA margin
4.6%
-5% vs 2024
Equity ratio
28.5%
Financial strength
Net profit 2025
SEK 27K
-96% vs 2024
| Revenue | SEK 17,6M | -3% |
| EBITDA | SEK 807K | -5% |
| Net profit | SEK 27K | -96% |
| Total assets | SEK 4,1M | -16% |
| Equity | SEK 1,2M | +2% |
| Employees | 6 | — |
Legal name
Galenica Derma AB
Org number
5593966996
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14 september 2022
Share capital
SEK 25 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utveckling, tillverkning och försäljning av läkemedel och läkemedelsnära produkter samt äga och förvalta aktier och fastigheter.
Address
Malmö
Email
info@galenica.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 14 321 | 18 040 | 17 556 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | −10 | −10 | 677 | 847 | 807 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −10 | −10 | 677 | 847 | 807 |
| Net financials | — | 0 | 5 | 12 | 29 |
| Profit before tax | 2 | 2 | 682 | 859 | 136 |
| Tax | −2 | 2 | −173 | −254 | −109 |
| Net profit | 0 | 0 | 509 | 605 | 27 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 27 | 27 | 3 206 | 4 856 | 4 098 |
| Equity | 25 | 25 | 534 | 1 139 | 1 166 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 | 2 | 2 672 | 3 717 | 2 932 |
| Total debt | 2 | 2 | 2 672 | 3 717 | 2 932 |
EBITDA margin
4.6%
This company
15.8%
Market median
-71% vs market
20222025
Equity ratio
28.5%
This company
38.2%
Market median
-25% vs market
20222025
Return on equity
2.3%
This company
18.4%
Market median
-88% vs market
20222025
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20222025
Asset turnover
4.28×
This company
1.12×
Market median
+282% vs market
20222025
Debt / equity
2.51×
This company
0.62×
Market median
-305% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-09-14 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-09-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AL Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
PO | Audit | 2022 – 2024 |
ME Chief Auditor | Chief Auditor | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Galenica AB
Galenica Derma AB Board members of Galenica Derma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Paul Olof Jakob Ekman | Audit | 0 companies |
| Ann Linnéa E Rickard Nilsson | Chief Auditor | 0 companies |
| My Elisabeth Lidén | Chief Auditor | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Ronnie Stefan Wallin | Chairman | 0 companies |
| Ulf Henri Hansson | Board of Directors | 0 companies |
| Lena Marie Örtenblad | Deputy Board Member | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |